Computational design of actinium-225 chelators for use in targeted alpha therapy

被引：0
|
作者：
Morgenstern, Amanda [1 ]
Lilley, Laura [1 ]
Stein, Benjamin [1 ]
Kozimor, Stosh [1 ]
Batista, Enrique [1 ]
Yang, Ping [1 ]
机构：
[1] Los Alamos Natl Lab, Los Alamos, NM USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
22-NUCL
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Invited Perspectives and Reviews Actinium-225 Targeted Agents: Where Are We Now?
    Mourtada, Firas
    Tomiyoshi, Katsumi
    Sims-Mourtada, Jennifer
    Mukai-Sasaki, Yuki
    Yagihashi, Takayuki
    Namiki, Yuta
    Murai, Taro
    Yang, David J.
    Inoue, Tomio
    BRACHYTHERAPY, 2023, 22 (06) : 697 - 708
  • [32] The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications
    Radchenko, Valery
    Schaffer, Paul
    Knapp, F. F. , Jr.
    CURRENT RADIOPHARMACEUTICALS, 2018, 11 (03) : 154 - 155
  • [33] Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis
    Ninatti, Gaia
    Scilipoti, Pietro
    Pini, Cristiano
    Barletta, Francesco
    Longoni, Mattia
    Gelardi, Fabrizia
    Sollini, Martina
    Gandaglia, Giorgio
    Sathekge, Mike
    Montorsi, Francesco
    Chiti, Arturo
    Briganti, Alberto
    THERANOSTICS, 2025, 15 (08): : 3386 - 3399
  • [34] Regulating alpha-emitting radioisotopes and specific considerations for actinium-225 containing actinium-227
    Shober, Megan
    APPLIED RADIATION AND ISOTOPES, 2022, 187
  • [35] Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227
    Anderson, Peter M. M.
    Subbiah, Vivek
    Trucco, Matteo M. M.
    FRONTIERS IN MEDICINE, 2022, 9
  • [36] Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
    Shi, Mengqi
    Jakobsson, Vivianne
    Greifenstein, Lukas
    Khong, Pek-Lan
    Chen, Xiaoyuan
    Baum, Richard P.
    Zhang, Jingjing
    FRONTIERS IN MEDICINE, 2022, 9
  • [37] Precise Monte Carlo Simulations of NaI(Tl) Spectra for Measurement of Actinium-225 Targeted Alpha Particle Bio-Distribution
    Tichacek, Christopher J.
    Budzevich, Mikalai M.
    Martinez, Gary V.
    Morse, David L.
    Moros, Eduardo G.
    MEDICAL PHYSICS, 2017, 44 (06) : 3227 - 3228
  • [38] CD46 targeted, Actinium-225 labelled antibody for treatment of prostate cancer xenografts
    Bidkar, Anil
    Wang, Sinan
    Bobba, Kondapa
    Bidlingmaier, Scott
    Su, Yang
    Egusa, Emily
    Tang, Ryan
    Chou, Jonathan
    Aggarwal, Rahul
    He, Jiang
    Seo, Youngho
    Liu, Bin
    Flavell, Robert
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S31 - S31
  • [39] Development of an anti-TMEM180 antibody conjugated with the alpha particle emitter actinium-225
    Nozomi, Iwata
    Takashima, Hiroki
    Koga, Yoshikatsu
    Ohnuki, Kazunobu
    Fujii, Hirofumi
    Matsumura, Yasuhiro
    Yasunaga, Masahiro
    CANCER SCIENCE, 2021, 112 : 919 - 919
  • [40] Production of actinium-225 from a (n,p) reaction: Feasibility and pre-design studies
    Abolaban, Fouad A.
    Banoqitah, Essam M.
    Taha, Eslam M.
    Alhawsawi, Abdulsalam M.
    Djouider, Fathi A.
    Nisbet, Andrew
    NUKLEONIKA, 2021, 66 (02) : 61 - 67
12345